Clinical Subphenotypes of Staphylococcus aureus Bacteremia
Clinical Infectious Diseases · 22.11.2024 · 79 (5) · 1153-1161
DOI: 10.1093/cid/ciae338 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 25.06.2024. Verfasst von Maaike C Swets und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Leiden University Medical Center, Leiden University, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Bacteremia, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, National Institute for Health Research, Wellcome Trust.
Abstract (Originalsprache)
Background
Staphylococcus aureus bacteremia (SAB) is a clinically heterogeneous disease. The ability to identify subgroups of patients with shared traits (subphenotypes) is an unmet need to allow patient stratification for clinical management and research. We aimed to test the hypothesis that clinically relevant subphenotypes can be reproducibly identified among patients with SAB.
Methods
We studied 3 cohorts of adults with monomicrobial SAB: a UK retrospective observational study (Edinburgh cohort, n = 458), the UK ARREST trial (n = 758), and the Spanish SAFO trial (n = 214). Latent class analysis was used to identify subphenotypes using routinely collected clinical data without considering outcomes. Mortality and microbiologic outcomes were then compared between subphenotypes.
Results
Included patients had predominantly methicillin-susceptible SAB (1366 of 1430, 95.5%). We identified 5 distinct, reproducible clinical subphenotypes: (A) SAB associated with older age and comorbidity, (B) nosocomial intravenous catheter-associated SAB in younger people without comorbidity, (C) community-acquired metastatic SAB, (D) SAB associated with chronic kidney disease, and (E) SAB associated with injection drug use. Survival and microbiologic outcomes differed between the subphenotypes. Mortality was highest in subphenotype A and lowest in subphenotypes B and E. Microbiologic outcomes were worse in subphenotype C. In a secondary analysis of the ARREST trial, adjunctive rifampicin was associated with increased mortality in subphenotype B and improved microbiologic outcomes in subphenotype C.
Conclusions
We have identified reproducible and clinically relevant subphenotypes within SAB and provide proof of principle of differential treatment effects. Through clinical trial enrichment and patient stratification, these subphenotypes could contribute to a personalized medicine approach to SAB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
- Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.
- Department of Methodology and Statistics, Leiden University, Leiden, The Netherlands.
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom.
- Clinical Infection Research Group, Western General Hospital, Edinburgh, United Kingdom.
- Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.
ORCID-Profile: Clark D Russell
Förderung
- Department of Health
- National Institute for Health Research
- Wellcome Trust
- NIAID NIH HHS
- NIH HHS
- Medical Research Council
- NHS
- National Institutes of Health
Zitieren
APA
Swets, M. C., Bakk, Z., Westgeest, A. C., Berry, K., Cooper, G., Sim, W., Lee, R. S., Gan, T. Y., Donlon, W., Besu, A., Heppenstall, E., Tysall, L., Dewar, S., de Boer, M., Fowler, V. G., Dockrell, D. H., Thwaites, G. E., Pujol, M., Pallarès, N., …, & Russell, C. D. (2024). Clinical Subphenotypes of Staphylococcus aureus Bacteremia. Clinical Infectious Diseases, 79(5), 1153-1161. https://doi.org/10.1093/cid/ciae338
Vancouver
Swets MC, Bakk Z, Westgeest AC, Berry K, Cooper G, Sim W, et al. Clinical Subphenotypes of Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 2024;79(5):1153-1161. doi:10.1093/cid/ciae338
BibTeX
@article{Swets2024,
author = {Swets, Maaike C and Bakk, Zsuzsa and Westgeest, Annette C and Berry, Karla and Cooper, George and Sim, Wynne and Lee, Rui Shian and Gan, Tze Yi and Donlon, William and Besu, Antonia and Heppenstall, Emily and Tysall, Luke and Dewar, Simon and de Boer, Mark and Fowler, Vance G and Dockrell, David H and Thwaites, Guy E and Pujol, Miquel and Pallarès, Natàlia and Tebé, Cristian and Carratalà, Jordi and Szubert, Alexander and Groeneveld, Geert H and Russell, Clark D},
title = {Clinical Subphenotypes of Staphylococcus aureus Bacteremia},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {5},
pages = {1153--1161},
doi = {10.1093/cid/ciae338}
}
EUVIMED